# COX-2 Inhibition in Allergic Asthma

> **NCT01002690** · NA · COMPLETED · sponsor: **Barbro Dahlen** · enrollment: 16 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Etoricoxib

## Key facts

- **NCT ID:** NCT01002690
- **Lead sponsor:** Barbro Dahlen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002690, "COX-2 Inhibition in Allergic Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01002690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*